Shankar Musunuri
2020
In 2020, Shankar Musunuri earned a total compensation of $1.6M as Chief Executive Officer at Histogenics, a 171% increase compared to previous year.
Compensation breakdown
| Bonus | $269,273 |
|---|---|
| Option Awards | $771,505 |
| Salary | $500,000 |
| Other | $11,400 |
| Total | $1,552,178 |
Musunuri received $771.5K in option awards, accounting for 50% of the total pay in 2020.
Musunuri also received $269.3K in bonus, $500K in salary and $11.4K in other compensation.
Rankings
In 2020, Shankar Musunuri's compensation ranked 6,689th out of 13,090 executives tracked by ExecPay. In other words, Musunuri earned more than 48.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,689 out of 13,090 | 49th |
Division Manufacturing | 2,781 out of 5,621 | 51st |
Major group Chemicals And Allied Products | 1,124 out of 2,254 | 50th |
Industry group Drugs | 970 out of 1,954 | 50th |
Industry Biological Products, Except Diagnostic Substances | 230 out of 411 | 44th |
Source: SEC filing on April 28, 2021.
Musunuri's colleagues
We found three more compensation records of executives who worked with Shankar Musunuri at Histogenics in 2020.